Cara Therapeutics, Inc. Company Profile

19:11 EDT 30th June 2016 | BioPortfolio

News Articles [1306 Associated News Articles listed on BioPortfolio]

Unser Setup für: Cara Therapeutics (CARA)

Rückblick: Die Aktie des Biotechnologiekonzerns Cara Therapeutics gehört zweifelsohne zu den äußerst spekulativen Aktien an der Wall Street und sollte eher von erfahrenen Anlegern in die Hand geno...

BRIEF-Cara Therapeutics reports Q1 loss per share $0.39

* Cara Therapeutics reports first quarter 2016 financial results

Cara Therapeutics' (CARA) CEO Dr. Derek Chalmers on Q4 2015 Results - Earnings Call Transcript

Cara Therapeutics Inc's (CARA) CEO Dr. Derek Chalmers on Q1 2016 Results - Earnings Call Transcript

MVM closes fourth fund at $233M

MVM Life Science Partners closed its fourth fund, MVM IV, at $233 million. The firm said it will invest $15-$30 million per company in healthcare companies of all stages in the U.S. and Europe. MVM in...

FDA removes clinical hold Cara Therapeutics' postoperative pain trial for I.V. CR845

The US Food and Drug Administration (FDA) has removed the clinical hold on Cara Therapeutics' adaptive phase 3 clinical trial assessing an intravenous formulation (I.V.) of lead product candidate CR84...

Cara tumbles after hours on clinical hold

Cara Therapeutics Inc. (NASDAQ:CARA) fell $2.91 (42%) to $4 in early after-hours trading after it said FDA placed a protocol clinical hold on its Phase III trial of IV CR845 to treat acute postoperati...

BRIEF-Cara therapeutics announces removal of FDA clinical hold on I.V. CR845 trial

* Cara therapeutics announces removal of FDA clinical hold on clin3001 postoperative pain trial for i.v. Cr845

PubMed Articles [500 Associated PubMed Articles listed on BioPortfolio]

Injectable biomaterials: a perspective on the next wave of injectable therapeutics.

We are experiencing a new wave of injectable therapeutics (namely/injectable biomaterials) to complement injectable drugs and injectable biologics, and to serve as the basis for injectable combinatori...

United across the pond.

LAST YEAR, 19-year-old Cara Farella survived a near-fatal asthma attack. While she cannot remember the details of her ordeal, she easily recalls how nurses who cared for her made her feel. 'I was far ...

Pigmentation and Macular Degeneration: Is There a Role for GPR143?

Fit for the Eye: Aptamers in Ocular Disorders.

For any new class of therapeutics, there are certain types of indications that represent a natural fit. For nucleic acid ligands in general, and aptamers in particular, the eye has historically been a...

Eyes on New Product Development.

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Metabolomic Approach to Evaluate the Effect of Orange Juice Intake in Healthy Humans (METABORANGE).

This study evaluates the effect of intake of two orange juice varieties in healthy adults. The participants will receive "Bahia" orange juice, "Cara-Cara" orange juice or a isocaloric cont...

Localized Therapeutics for the Treatment of Gastrointestinal Disorders II

The purpose of this study is to investigate a novel thermosensitive topical gel formulation for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis.

Heart Rate Variability Biofeedback: It's Role in Asthma Therapeutics

The goal of this research study to see whether biofeedback therapy helps treat asthma, and if so, how it works. Biofeedback is a treatment method that can teach people how to control their...

Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial Program

Caring for patients with Alzheimer Disease or Related Disorders (ADRD) is accompanied with a caregiver burden that increases with the progression of the disease. This burden can have physi...

Protecting the 'Hood Against Tobacco

Among all racial/ethnic groups, African Americans have the greatest risk of becoming ill or dying from tobacco-related diseases. Because of this disproportionate disease burden, it is part...

Companies [4 Associated Companies listed on BioPortfolio]

CARA Therapeutics

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has enter...

Cara Therapeutics, Inc.


Instituto de Cirugía Maxilofacial e Implantología

Me es grato darles la bienvenida a la página web del INSTITUTO DE CIRUGIA MAXILOFACIAL E IMPLANTOLOGIA.El Instituto, fundado en Mayo del 2000, tiene como objetivo el tratamiento integral médico-quir...

More Information about "Cara Therapeutics, Inc." on BioPortfolio

We have published hundreds of Cara Therapeutics, Inc. news stories on BioPortfolio along with dozens of Cara Therapeutics, Inc. Clinical Trials and PubMed Articles about Cara Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cara Therapeutics, Inc. Companies in our database. You can also find out about relevant Cara Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record